https://www.ukhealthcaregazette.com/article/905669089-vetter-strengthens-its-global-clinical-manufacturing-network-with-strategic-site-enhancements UK Healthcare Gazette en PressRelease 2026-04-14T12:23:56+00:00 Vetter Strengthens its Global Clinical Manufacturing Network with Strategic Site Enhancements https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24832286-des-plaines-site-2856x2142.jpeg https://www.ukhealthcaregazette.com/article/905494291-the-nssc-releases-statement-following-stephenson-king-jr-s-death-a-triple-systemic-failure UK Healthcare Gazette en PressRelease 2026-04-14T12:00:00+00:00 The NSSC Releases Statement Following Stephenson King Jr.'s Death: A Triple Systemic Failure https://www.ukhealthcaregazette.com/article/905590355-krown-technologies-inc-announces-exclusive-6-year-partnership-with-btc-inc-naming-qastle-official-quantum-wallet UK Healthcare Gazette en PressRelease 2026-04-14T10:30:00+00:00 Krown Technologies Inc. Announces Exclusive 6-Year Partnership with BTC Inc., naming Qastle Official Quantum Wallet https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24832039-krown-technologies-and-btc-inc-1366x768.jpeg https://www.ukhealthcaregazette.com/article/905650380-research-suggests-dental-floss-material-properties-may-influence-whether-patients-keep-flossing UK Healthcare Gazette en PressRelease 2026-04-14T10:23:20+00:00 Research Suggests Dental Floss Material Properties May Influence Whether Patients Keep Flossing https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24832200-floss-microscopic-image-1600x900.png https://www.ukhealthcaregazette.com/article/905650047-raltron-introduces-comprehensive-line-of-precision-piezo-electric-elements-for-medical-and-advanced-audio-applications UK Healthcare Gazette en PressRelease 2026-04-14T10:21:08+00:00 Raltron Introduces Comprehensive Line of Precision Piezo-Electric Elements for Medical and Advanced Audio Applications https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24832217-ral1483-pr-image-900x470.png https://www.ukhealthcaregazette.com/article/905639051-what-drives-wuxi-apptec-s-25-year-compliance-record-and-why-does-it-matter-for-global-partnerships UK Healthcare Gazette en PressRelease 2026-04-14T09:10:29+00:00 What Drives WuXi AppTec’s 25-Year Compliance Record, and Why Does It Matter for Global Partnerships? https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24832182-a-global-company-operating-in-a-1920x1080.jpeg https://www.ukhealthcaregazette.com/article/905524434-rising-nhs-costs-and-uk-safety-concerns-are-changing-the-conversation-around-surgery-abroad UK Healthcare Gazette en PressRelease 2026-04-14T08:30:00+00:00 Rising NHS Costs and UK Safety Concerns Are Changing the Conversation Around Surgery Abroad https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24831686-health-uk-1904x1071.jpeg https://www.ukhealthcaregazette.com/article/905613472-how-wuxi-apptec-drives-a-more-connected-and-collaborative-life-sciences-ecosystem UK Healthcare Gazette en PressRelease 2026-04-14T06:31:13+00:00 How WuXi AppTec Drives a More Connected and Collaborative Life Sciences Ecosystem https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24832105-the-wuxi-global-forum-975x427.png https://www.ukhealthcaregazette.com/article/905481717-shuwen-biotech-receives-exclusive-patent-license-from-cologne-university UK Healthcare Gazette en PressRelease 2026-04-14T06:00:00+00:00 Shuwen Biotech Receives Exclusive Patent License from Cologne University https://www.ukhealthcaregazette.com/article/905585443-huaxuan-pharmaceutical-fish-gelatin-soft-capsules-manufacturer-quality-compliance-guaranteed UK Healthcare Gazette en PressRelease 2026-04-14T05:29:22+00:00 HUAXUAN: Pharmaceutical Fish Gelatin Soft Capsules Manufacturer | Quality & Compliance Guaranteed https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24832013-fish-gelatin-soft-capsules-chin-1133x755.png https://www.ukhealthcaregazette.com/article/905597460-regenerative-medicine-market-set-to-reach-us-150-2-bn-by-2033-says-persistence-market-research UK Healthcare Gazette en PressRelease 2026-04-14T04:51:48+00:00 Regenerative Medicine Market Set to Reach US$150.2 Bn by 2033, Says Persistence Market Research https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24832059-regenerative-medicine-market-1040x720.png https://www.ukhealthcaregazette.com/article/905060499-dr-mohana-rao-patibandla-featured-in-forbes-india-among-game-changing-healthcare-leaders UK Healthcare Gazette en PressRelease 2026-04-14T04:30:00+00:00 Dr. Mohana Rao Patibandla Featured in Forbes India Among Game-Changing Healthcare Leaders https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/22738408-advanced-biplane-cath-lab-at-dr-1200x801.jpeg https://www.ukhealthcaregazette.com/article/905647186-nxera-pharma-s-quviviq-daridorexant-25mg-and-50mg-receives-approval-in-taiwan-for-the-treatment-of-insomnia UK Healthcare Gazette en PressRelease 2026-04-14T08:42:59+00:00 Nxera Pharma’s QUVIVIQ® (daridorexant) 25mg and 50mg Receives Approval in Taiwan for the Treatment of Insomnia https://ml-eu.globenewswire.com/media/5cc74d52-c86f-4e21-8684-3496281fee15/small/nxera-master-logo-rgb-black-1-png.png https://www.ukhealthcaregazette.com/article/905636102-mestag-therapeutics-selected-to-present-targeted-ltbr-agonist-mst-0312-in-late-breaking-session-at-aacr-annual-meeting UK Healthcare Gazette en PressRelease 2026-04-14T07:30:00+00:00 Mestag Therapeutics Selected to Present Targeted LTBR Agonist MST‑0312 in Late‑Breaking Session at AACR Annual Meeting https://ml-eu.globenewswire.com/media/d47c1200-a3a8-42b0-b0b9-ffb74568b42c/small/mestag-tx-logo-png.png https://www.ukhealthcaregazette.com/article/905614774-renaissance-pharma-limited-an-essential-pharma-company-secures-fda-fast-track-designation-and-ind-clearance-for-daretabart-hu1418k322a-in UK Healthcare Gazette en PressRelease 2026-04-14T06:00:00+00:00 Renaissance Pharma Limited, an Essential Pharma company, secures FDA Fast Track Designation and IND clearance for Daretabart (hu1418K322A) in high-risk neuroblastoma https://ml-eu.globenewswire.com/media/31276511-f379-4a7a-90b6-af9fc9ac2aa0/small/66795319ca361c8d044a2cc6-essential-pharma-master-logo-png.png https://www.ukhealthcaregazette.com/article/905498034-krown-technologies-achieves-iso-iec-27001-2022-certification-for-information-security-management UK Healthcare Gazette en PressRelease 2026-04-13T15:41:51+00:00 Krown Technologies Achieves ISO/IEC 27001:2022 Certification for Information Security Management https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24831467-krown-iso-27001-cert-graphic-pr-1366x768.jpeg https://www.ukhealthcaregazette.com/article/905425078-pulmonary-embolism-market-to-reach-us-4-3-bn-by-2033-at-9-5-cagr-persistence-market-research UK Healthcare Gazette en PressRelease 2026-04-13T15:00:00+00:00 Pulmonary Embolism Market to Reach US$4.3 Bn by 2033 at 9.5% CAGR: Persistence Market Research https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24831017-pulmonary-embolism-pe-market-1040x720.png https://www.ukhealthcaregazette.com/article/905593433-rapid-nutrition-strengthens-capital-markets-infrastructure-with-appointment-of-bowsprit-partners UK Healthcare Gazette en PressRelease 2026-04-14T03:00:00+00:00 Rapid Nutrition Strengthens Capital Markets Infrastructure with Appointment of Bowsprit Partners https://ml-eu.globenewswire.com/media/f5152816-94d7-4584-a49f-05ae66a44bf0/small/rapid-jpg.jpg https://www.ukhealthcaregazette.com/article/905488870-how-transformers-are-rewiring-graph-based-recommendation UK Healthcare Gazette en PressRelease 2026-04-13T14:23:09+00:00 How transformers are rewiring graph-based recommendation https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24831349-conceptual-overview-of-a-gtrs-1564x426.jpeg https://www.ukhealthcaregazette.com/article/905394210-merit-awards-announces-winners-of-the-2026-marketing-communications-awards UK Healthcare Gazette en PressRelease 2026-04-13T13:00:00+00:00 Merit Awards Announces Winners of the 2026 Marketing & Communications Awards https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24746355-2026-merit-awards-logo-1238x518.png https://www.ukhealthcaregazette.com/article/904984928-applications-open-for-dnda26-awards-celebrating-humanity-centered-design-for-societal-impact-and-global-well-being UK Healthcare Gazette en PressRelease 2026-04-13T11:00:00+00:00 Applications Open for DNDA26 Awards: Celebrating Humanity-Centered Design for Societal Impact and Global Well-Being https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24830562-dnda25-laureates-3240x2160.jpeg https://www.ukhealthcaregazette.com/article/905451568-dr-bar-keklik-calls-for-greater-transparency-as-uk-patients-explore-breast-surgery-abroad UK Healthcare Gazette en PressRelease 2026-04-13T09:59:06+00:00 Dr Barış Keklik Calls for Greater Transparency as UK Patients Explore Breast Surgery Abroad https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24831171-dr-bar-keklik-2204x1239.jpeg https://www.ukhealthcaregazette.com/article/905432255-top-high-speed-handpiece-manufacturers-driving-a-new-standard-in-dental-equipment UK Healthcare Gazette en PressRelease 2026-04-13T06:40:32+00:00 Top High Speed Handpiece Manufacturers Driving a New Standard in Dental Equipment https://www.ukhealthcaregazette.com/article/905433468-top-desiccant-manufacturers-driving-change-in-global-moisture-control-markets UK Healthcare Gazette en PressRelease 2026-04-13T06:38:11+00:00 Top Desiccant Manufacturers Driving Change in Global Moisture Control Markets https://www.ukhealthcaregazette.com/article/905423805-cervical-cancer-treatment-market-to-reach-us-14-6-bn-by-2033-says-persistence-market-research UK Healthcare Gazette en PressRelease 2026-04-13T05:33:46+00:00 Cervical Cancer Treatment Market to Reach US$14.6 bn by 2033 Says Persistence Market Research https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24831015-cervical-cancer-treatment-marke-1040x720.png https://www.ukhealthcaregazette.com/article/904870611-jeio-tech-celebrates-10-year-partnership-with-seeding-labs-to-advance-global-scientific-research UK Healthcare Gazette en PressRelease 2026-04-13T05:32:31+00:00 Jeio Tech Celebrates 10-Year Partnership with Seeding Labs to Advance Global Scientific Research https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/23927274-jeio-tech-global-network-1110x551.jpeg https://www.ukhealthcaregazette.com/article/905466754-oxb-launches-fast-track-offering-for-aav-and-lentiviral-vector-platforms-accelerating-viral-vector-development-and-manufacture UK Healthcare Gazette en PressRelease 2026-04-13T11:00:00+00:00 OXB launches fast-track offering for AAV and lentiviral vector platforms, accelerating viral vector development and manufacture https://ml-eu.globenewswire.com/media/3e905c0a-b28c-4981-ac57-745647779ad9/small/oxb-new-logo-png.png https://www.ukhealthcaregazette.com/article/905432318-synox-therapeutics-announces-positive-topline-results-from-the-phase-3-tangent-study-supporting-emactuzumab-as-a-differentiated-next-generation UK Healthcare Gazette en PressRelease 2026-04-13T06:00:00+00:00 SynOx Therapeutics Announces Positive Topline Results from the Phase 3 TANGENT Study, Supporting Emactuzumab as a Differentiated, Next-generation Treatment for Patients with Tenosynovial Giant Cell Tumor (TGCT) https://ml.globenewswire.com/media/35d87dbe-62e3-4299-9eba-3ccdbea5d85e/small/synox-logo-jpg.jpg https://www.ukhealthcaregazette.com/article/905385512-nxera-pharma-s-partner-neurocrine-biosciences-doses-first-patient-in-phase-2-trial-of-nbi-1117570-for-adults-with-schizophrenia UK Healthcare Gazette en PressRelease 2026-04-12T23:30:00+00:00 Nxera Pharma’s Partner Neurocrine Biosciences Doses First Patient in Phase 2 Trial of NBI-1117570 for Adults with Schizophrenia https://ml-eu.globenewswire.com/media/5cc74d52-c86f-4e21-8684-3496281fee15/small/nxera-master-logo-rgb-black-1-png.png